1 results match your criteria: "Novartis Institutes for BioMedical Research Basel Switzerland richard.stein@novartis.com hans-joerg.roth@novartis.com.[Affiliation]"
There is an increasing interest to develop therapeutics that modulate challenging or undruggable target proteins a mechanism that involves ternary complexes. In general, such compounds can be characterized by their direct affinities to a chaperone and a target protein and by their degree of cooperativity in the formation of the ternary complex. As a trend, smaller compounds have a greater dependency on intrinsic cooperativity to their thermodynamic stability relative to direct target (or chaperone) binding.
View Article and Find Full Text PDF